Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
2020
(4)
2019
(1)
2018
(1)
2015
(1)
Decision
Transfer
(7)
Complainant
Vivendi
(2)
Boehringer Ingelheim Pharma GmbH & Co. KG
(1)
Boehringer Ingelheim International Gmbh.
(1)
BOLLORE SE
(1)
BOEHRINGER Ingelheim Pharma GmbH & Co. KG
(1)
Respondent
赵竹飞 (Zhao Zhu Fei)
(1)
宫宁 (gongning)
(1)
域名管理2
(1)
Wuchaowen
(1)
Wang Lian Feng
(1)
Jin Shou Deng( 邓金寿)
(1)
Data Protected Limited
(1)
Panelist
Sebastian M.W. Hughes
(2)
Deanna Wong Wai Man
(2)
Susanna H.S. Leong
(1)
Matthew Kennedy
(1)
Douglas Clark
(1)
Complainant Country
France
(4)
Germany
(3)
Complainant Representative
Nameshield
(7)
Respondent Country
China
(7)
Respondent Reply
Yes
(4)
No
(3)
RDNH Status
No
(7)
Case Language
English
(7)
Case Particular
D
(7)
Number Of Domains
1
(4)
2
(1)
3
(1)
4
(1)
Domain Extension
online
(2)
网址
(1)
wang
(1)
tech
(1)
site
(1)
shop
(1)
luxe
(1)
ltd
(1)
icu
(1)
Domain Extension Type
newgTLD
(7)
Domain Length
7
(7)
8
(1)
10
(1)
Includes Hyphen
No
(7)
Includes Number
No
(7)
Includes Letter
Yes
(7)
Domain Registrar
Alibaba Cloud Computing Ltd. d/b/a HiChina (www.net.cn)
(3)
West263 International Limited
(1)
Internet Domain Name System Beijing Engineering Research Center LLC (ZDNS)
(1)
DNSPod, Inc.
(1)
7
cases found.
Case Language: English
Complainant Representative: Nameshield
Domain Extension Type: newgTLD
Domain Length: 7
Respondent Country: China
Reset Search
giotrif.icu
Transfer
WIPO D2020-0759
(Decision Date: June 11, 2020)
vivendi.shop, vivendi.tech, vivendi.wang
Transfer
WIPO D2020-0740
(Decision Date: May 21, 2020)
bollore.online
Transfer
WIPO D2020-0691
(Decision Date: May 15, 2020)
vivendi.ltd
Transfer
WIPO D2019-2792
(Decision Date: Jan. 8, 2020)
vivendi.luxe
Transfer
WIPO D2019-1414
(Decision Date: Sept. 6, 2019)
giotrif.online, giotrif.site
Transfer
WIPO D2018-0562
(Decision Date: May 14, 2018)
boehringer.网址, micardis.网址, mucosolvan.网址 and spiriva.网址
Transfer
WIPO D2015-0049
(Decision Date: March 9, 2015)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll